These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 37160700)

  • 1. Exact sample size determination for a single Poisson random sample.
    Gentile S; Sambucini V
    Biom J; 2023 Oct; 65(7):e2200183. PubMed ID: 37160700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bayesian sample-size determination for two independent Poisson rates.
    Hand AL; Stamey JD; Young DM
    Comput Methods Programs Biomed; 2011 Nov; 104(2):271-7. PubMed ID: 21146897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sample size determination for a binary response in a superiority clinical trial using a hybrid classical and Bayesian procedure.
    Ciarleglio MM; Arendt CD
    Trials; 2017 Feb; 18(1):83. PubMed ID: 28231813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal sample size determination for single-arm trials in pediatric and rare populations with Bayesian borrowing.
    Ji Z; Lin J; Lin J
    J Biopharm Stat; 2022 Jul; 32(4):529-546. PubMed ID: 35604836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Bayesian-frequentist two-stage single-arm phase II clinical trial design.
    Dong G; Shih WJ; Moore D; Quan H; Marcella S
    Stat Med; 2012 Aug; 31(19):2055-67. PubMed ID: 22415966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selection of the effect size for sample size determination for a continuous response in a superiority clinical trial using a hybrid classical and Bayesian procedure.
    Ciarleglio MM; Arendt CD; Peduzzi PN
    Clin Trials; 2016 Jun; 13(3):275-85. PubMed ID: 26928986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hybrid classical-Bayesian approach to sample size determination for two-arm superiority clinical trials.
    Sambucini V
    Int J Biostat; 2024 Jul; ():. PubMed ID: 38943460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selection of the treatment effect for sample size determination in a superiority clinical trial using a hybrid classical and Bayesian procedure.
    Ciarleglio MM; Arendt CD; Makuch RW; Peduzzi PN
    Contemp Clin Trials; 2015 Mar; 41():160-71. PubMed ID: 25583273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bayesian sample size determination in a three-arm non-inferiority trial with binary endpoints.
    Tang N; Yu B
    J Biopharm Stat; 2022 Sep; 32(5):768-788. PubMed ID: 35213275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bayesian single-arm phase II trial designs with time-to-event endpoints.
    Wu J; Pan H; Hsu CW
    Pharm Stat; 2021 Nov; 20(6):1235-1248. PubMed ID: 34085764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Bayesian Hybrid Adaptive Randomisation Design for Clinical Trials with Survival Outcomes.
    Moatti M; Chevret S; Zohar S; Rosenberger WF
    Methods Inf Med; 2016; 55(1):4-13. PubMed ID: 26404511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Bayesian predictive sample size selection design for single-arm exploratory clinical trials.
    Teramukai S; Daimon T; Zohar S
    Stat Med; 2012 Dec; 31(30):4243-54. PubMed ID: 22807115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [BAYESIAN SAMPLE SIZE DETERMINATION FOR CYTOGENETIC STUDIES IN A POPULATION].
    Tikaradze E; Sharashenidze G; Sanikidze T; Jafaridze S; Ormotsadze G
    Georgian Med News; 2020 Mar; (300):124-128. PubMed ID: 32383715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Bayesian sequential design using alpha spending function to control type I error.
    Zhu H; Yu Q
    Stat Methods Med Res; 2017 Oct; 26(5):2184-2196. PubMed ID: 26187736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving efficiency in the stepped-wedge trial design via Bayesian modeling with an informative prior for the time effects.
    Zhan D; Ouyang Y; Xu L; Wong H
    Clin Trials; 2021 Jun; 18(3):295-302. PubMed ID: 33813906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sample size re-estimation in a superiority clinical trial using a hybrid classical and Bayesian procedure.
    Ciarleglio MM; Arendt CD
    Stat Methods Med Res; 2019 Jun; 28(6):1852-1878. PubMed ID: 29869564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The choice of sample size: a mixed Bayesian / frequentist approach.
    Pezeshk H; Nematollahi N; Maroufy V; Gittins J
    Stat Methods Med Res; 2009 Apr; 18(2):183-94. PubMed ID: 18445695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bayesian sample size determination for longitudinal studies with continuous response based on different scientific questions of interest.
    Baghfalaki T
    J Biopharm Stat; 2019; 29(2):244-270. PubMed ID: 30359549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of the optimal sample size for a clinical trial accounting for the population size.
    Stallard N; Miller F; Day S; Hee SW; Madan J; Zohar S; Posch M
    Biom J; 2017 Jul; 59(4):609-625. PubMed ID: 27184938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bayesian model selection techniques as decision support for shaping a statistical analysis plan of a clinical trial: an example from a vertigo phase III study with longitudinal count data as primary endpoint.
    Adrion C; Mansmann U
    BMC Med Res Methodol; 2012 Sep; 12():137. PubMed ID: 22962944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.